Edgestream Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,338
Closed -$236K 860
2025
Q1
$236K Sell
2,338
-20,766
-90% -$2.09M 0.01% 786
2024
Q4
$2.06M Buy
+23,104
New +$2.06M 0.09% 392
2024
Q3
Sell
-8,796
Closed -$677K 854
2024
Q2
$677K Buy
8,796
+3,455
+65% +$266K 0.03% 615
2024
Q1
$366K Buy
+5,341
New +$366K 0.02% 690
2023
Q3
Sell
-8,930
Closed -$483K 824
2023
Q2
$483K Buy
+8,930
New +$483K 0.04% 534
2022
Q3
Sell
-27,073
Closed -$1.01M 460
2022
Q2
$1.01M Sell
27,073
-21,769
-45% -$811K 0.08% 322
2022
Q1
$2.16M Sell
48,842
-21,385
-30% -$947K 0.17% 199
2021
Q4
$2.98M Sell
70,227
-110,764
-61% -$4.7M 0.19% 163
2021
Q3
$7.85M Sell
180,991
-208,472
-54% -$9.05M 0.49% 56
2021
Q2
$16.7M Buy
389,463
+150,714
+63% +$6.44M 0.98% 13
2021
Q1
$9.23M Buy
238,749
+2,915
+1% +$113K 0.52% 47
2020
Q4
$8.48M Buy
+235,834
New +$8.48M 0.43% 79
2020
Q3
Sell
-752,567
Closed -$26.4M 291
2020
Q2
$26.4M Buy
752,567
+170,091
+29% +$5.97M 1.39% 13
2020
Q1
$19M Sell
582,476
-82,362
-12% -$2.69M 1.76% 8
2019
Q4
$30.1M Buy
664,838
+283,702
+74% +$12.8M 1.56% 7
2019
Q3
$15.5M Buy
381,136
+107,202
+39% +$4.36M 1.48% 11
2019
Q2
$11.8M Buy
273,934
+40,415
+17% +$1.74M 1.33% 19
2019
Q1
$8.96M Buy
+233,519
New +$8.96M 1.31% 18
2018
Q2
Sell
-18,898
Closed -$516K 261
2018
Q1
$516K Buy
18,898
+7,417
+65% +$203K 0.1% 181
2017
Q4
$285K Buy
+11,481
New +$285K 0.34% 68
2017
Q3
Sell
-47,756
Closed -$1.32M 120
2017
Q2
$1.32M Buy
+47,756
New +$1.32M 0.5% 45
2017
Q1
Sell
-24,686
Closed -$534K 139
2016
Q4
$534K Sell
24,686
-27,146
-52% -$587K 1.11% 29
2016
Q3
$1.23M Buy
+51,832
New +$1.23M 0.68% 38